Publication:
Economic Burden of Sars-cov-2 Patients with Multi-morbidity: A Systematic Review Protocol

Simple item page
dc.contributor.authorAmirah Azzerien_US
dc.contributor.authorMohd Noor Afiq Ramleeen_US
dc.contributor.authorMohd Iqbal Mohd Nooren_US
dc.contributor.authorMohd Hafiz Jaafaren_US
dc.contributor.authorThinni Nurul Rochmahen_US
dc.contributor.authorMaznah Dahluien_US
dc.date.accessioned2024-05-29T02:25:49Z
dc.date.available2024-05-29T02:25:49Z
dc.date.issued2022
dc.date.submitted2023-1-26
dc.descriptionVolume 19 Issue 20en_US
dc.description.abstractEconomic burden issues in SARS-CoV-2 patients with underlying co-morbidities are enormous resources for patient treatment and management. The uncertainty costs for clinical management render the healthcare system catatonic and incurs deficits in national annual budgets. This article focuses on systematic steps towards selecting and evaluating literature to uncover gaps and ways to help healthcare stakeholders optimize resources in treating and managing COVID-19 patients with multi-morbidity. A systematic review of all COVID-19 treatment procedures with co-morbidities or multi-morbidity for the period from 2019 to 2022 was conducted. The search includes studies describing treatment costs associated with multi- or co-morbidity cases for infected patients and, if concurrently reported, determining recurring expenses. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Galbraith plots and I2 statistics will be deployed to assess heterogeneity and to identify potential sources. A backward elimination process will be applied in the regression modelling procedure. Based on the number of studies retrieved and their sample size, the subgroup analysis will be stratified on participant disease category, associated total costs, and degree of freedom in cost estimation. These studies were registered in the PROSPERO registry (ID: CRD42022323071).en_US
dc.description.sponsorshipDepartment of Higher Education, Ministry of Higher Education Malaysia ( Ministry of Higher Education Malaysia 2021–2024, FRGS/1/2021/SSO/USIM/02/5, USIM/FRGS/FPSK/KPT/50621)en_US
dc.description.sponsorshipUniversiti Sains Islam Malaysia (PPPI/FPSK/0121/USIM/16321)en_US
dc.identifier.citationAzzeri, A.; Ramlee, M.N.A.; Noor, M.I.M.; Jaafar, M.H.; Rocmah, T.N.; Dahlui, M. Economic Burden of SARS-CoV-2 Patients with Multi-Morbidity: A Systematic Review Protocol. Int. J. Environ. Res. Public Health 2022, 19, 13157. https:// doi.org/10.3390/ijerph192013157en_US
dc.identifier.doi10.3390/ijerph192013157
dc.identifier.epage11
dc.identifier.issn1660-4601
dc.identifier.issue20
dc.identifier.spage1
dc.identifier.urihttps://www.mdpi.com/1660-4601/19/20/13157
dc.identifier.urihttps://www.scopus.com/record/display.uri?eid=2-s2.0-85140914884&origin=resultslist&sort=plf-f&src=s&sid=ff7b2cafb526bfeca0fe6ae95dfa2def&sot=b&sdt=b&s=TITLE-ABS-KEY%28%22%09Economic+Burden+Of+Sars-cov-2+Patients+With+Multi-morbidity%3A+A+Systematic+Review+Protocol%22%29&sl=113&sessionSearchId=ff7b2cafb526bfeca0fe6ae95dfa2def
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/10516
dc.identifier.volume19
dc.language.isoen_USen_US
dc.publisherMDPIen_US
dc.relation.ispartofInternational Journal Of Environmental Research And Public Healthen_US
dc.subjectCOVID-19; economic burden; comorbidity; cardio/cerebrovascular; diabetes; hypertension; respiratory diseasesen_US
dc.titleEconomic Burden of Sars-cov-2 Patients with Multi-morbidity: A Systematic Review Protocolen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Economic Burden Of Sars-cov-2 Patients With Multi-morbidity A Systematic Review Protocol.pdf
Size:
1 MB
Format:
Adobe Portable Document Format
Download

Collections

Scopus